Pfizer

Open: 27.18 Close: 26.93 Change: -0.25

The 16 top things that an AI found about Pfizer Stock and you do not know…

How much time have you spent trying to decide whether investing in Pfizer? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, company, …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer surprised Wall Street with an unexpected profit beat in its fourth quarter. Company blamed lower demand and “unfavorable timing of customer orders”

Today's News

Pfizer posted a surprise adjusted fourth-quarter profit as the companys declining Covid business lost less revenue than expected. Pfizer also reiterated its full-year 2024 guidance. Pfizer CEO Albert Bourla said RSV vaccine Abrysvo was a “bad launch” for the company. Pfizer execs shared muted enthusiasm for recent progress the company has made with its rollout. Company blamed lower demand and “unfavorable timing of customer orders” Pfizer kicked off Big Pharma earnings with a beat and GM posted solid results. Earlier in the day, Pfizer posted solid earnings results. Pfizer is out this morning with its fourth quarter results, seeing revenue from its COVID vaccine declined 53% year on year. Pfizer shares down slightly here, but so much of this is really about the company moving beyond that vaccine. Leerink Partners analysts said that Pfizer has maintained the guidance that they set. Pfizer (PFE) is one of the worlds largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Cantor Fitzgerald maintains a Buy rating on Pfizer. Pfizer surprised Wall Street with an unexpected profit beat in its fourth quarter. Pfizer expects full-year earnings in the range of $2.05 to $2.25 per share. The company expects to recover some of that revenue reversal this year. Pfizer debuted its 2024 forecast in December. The company had previously scaled back its sales expectations for 2023, which sent Pfizer shares plunging and contributed to a rough year for the stock. Pfizer made a net loss of $3.37 billion or 60 cents per share, but adjusted earnings amounted to 10 cents.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, company, share, earnings, year, sale, post, and the most common words in the summary are: pfizer, bloomberg, stock, vaccine, best, product, news, . One of the sentences in the summary was: Pfizer surprised Wall Street with an unexpected profit beat in its fourth quarter. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #bloomberg #stock #vaccine #best #product #news.